Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11389021rdf:typepubmed:Citationlld:pubmed
pubmed-article:11389021lifeskim:mentionsumls-concept:C0684336lld:lifeskim
pubmed-article:11389021lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:11389021lifeskim:mentionsumls-concept:C0042520lld:lifeskim
pubmed-article:11389021lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:11389021lifeskim:mentionsumls-concept:C0444669lld:lifeskim
pubmed-article:11389021lifeskim:mentionsumls-concept:C1136143lld:lifeskim
pubmed-article:11389021pubmed:issue12lld:pubmed
pubmed-article:11389021pubmed:dateCreated2001-6-4lld:pubmed
pubmed-article:11389021pubmed:abstractTextLeukocyte capture and rolling are mediated by selectins expressed on leukocytes (L-selectin) and the vascular endothelium (P- and E-selectin). To investigate the role of core 2 beta1-6-N-glucosaminyltransferase (C2GlcNAcT-I) for synthesis of functional selectin ligands in vivo, leukocyte rolling flux and velocity were studied in venules of untreated and tumor necrosis factor-alpha (TNFalpha)-pretreated autoperfused cremaster muscles of C2GlcNAcT-I-deficient (core 2(-/-)) and littermate control mice. In untreated core 2(-/-) mice, leukocyte rolling was dramatically reduced with markedly increased rolling velocities (81 +/- 4 microm/s vs 44 +/- 3 microm/s). The reduced rolling in core 2(-/-) mice was due mainly to severely impaired binding of P-selectin to P-selectin glycoprotein ligand-1 (PSGL-1). Some rolling remained after blocking PSGL-1 in controls but not in core 2(-/-) mice. In TNFalpha-pretreated mice, rolling was markedly reduced in core 2(-/-) mice owing to impaired P-selectin- and E-selectin-mediated rolling. Rolling velocities in core 2(-/-) mice treated with an E-selectin-blocking monoclonal antibody (59 +/- 4 microm/s) were significantly higher than in controls (14 +/- 1 microm/s), which provides further evidence for the severe impairment in P-selectin-mediated rolling. In conclusion, P-selectin ligands including PSGL-1 are largely C2GlcNAcT-I dependent. In addition, E-selectin-mediated rolling in vivo is partially dependent on the targeted C2GlcNAcT-I. (Blood. 2001;97:3812-3819)lld:pubmed
pubmed-article:11389021pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11389021pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11389021pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11389021pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11389021pubmed:languageenglld:pubmed
pubmed-article:11389021pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11389021pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11389021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11389021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11389021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11389021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11389021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11389021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11389021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11389021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11389021pubmed:statusMEDLINElld:pubmed
pubmed-article:11389021pubmed:monthJunlld:pubmed
pubmed-article:11389021pubmed:issn0006-4971lld:pubmed
pubmed-article:11389021pubmed:authorpubmed-author:RaevuoriMMlld:pubmed
pubmed-article:11389021pubmed:authorpubmed-author:ElliesL GLGlld:pubmed
pubmed-article:11389021pubmed:authorpubmed-author:LeyKKlld:pubmed
pubmed-article:11389021pubmed:authorpubmed-author:SperandioMMlld:pubmed
pubmed-article:11389021pubmed:authorpubmed-author:FoyDDlld:pubmed
pubmed-article:11389021pubmed:authorpubmed-author:ThatteAAlld:pubmed
pubmed-article:11389021pubmed:issnTypePrintlld:pubmed
pubmed-article:11389021pubmed:day15lld:pubmed
pubmed-article:11389021pubmed:volume97lld:pubmed
pubmed-article:11389021pubmed:ownerNLMlld:pubmed
pubmed-article:11389021pubmed:authorsCompleteYlld:pubmed
pubmed-article:11389021pubmed:pagination3812-9lld:pubmed
pubmed-article:11389021pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:11389021pubmed:meshHeadingpubmed-meshheading:11389021...lld:pubmed
pubmed-article:11389021pubmed:meshHeadingpubmed-meshheading:11389021...lld:pubmed
pubmed-article:11389021pubmed:meshHeadingpubmed-meshheading:11389021...lld:pubmed
pubmed-article:11389021pubmed:meshHeadingpubmed-meshheading:11389021...lld:pubmed
pubmed-article:11389021pubmed:meshHeadingpubmed-meshheading:11389021...lld:pubmed
pubmed-article:11389021pubmed:meshHeadingpubmed-meshheading:11389021...lld:pubmed
pubmed-article:11389021pubmed:meshHeadingpubmed-meshheading:11389021...lld:pubmed
pubmed-article:11389021pubmed:meshHeadingpubmed-meshheading:11389021...lld:pubmed
pubmed-article:11389021pubmed:meshHeadingpubmed-meshheading:11389021...lld:pubmed
pubmed-article:11389021pubmed:meshHeadingpubmed-meshheading:11389021...lld:pubmed
pubmed-article:11389021pubmed:meshHeadingpubmed-meshheading:11389021...lld:pubmed
pubmed-article:11389021pubmed:meshHeadingpubmed-meshheading:11389021...lld:pubmed
pubmed-article:11389021pubmed:meshHeadingpubmed-meshheading:11389021...lld:pubmed
pubmed-article:11389021pubmed:meshHeadingpubmed-meshheading:11389021...lld:pubmed
pubmed-article:11389021pubmed:meshHeadingpubmed-meshheading:11389021...lld:pubmed
pubmed-article:11389021pubmed:meshHeadingpubmed-meshheading:11389021...lld:pubmed
pubmed-article:11389021pubmed:meshHeadingpubmed-meshheading:11389021...lld:pubmed
pubmed-article:11389021pubmed:year2001lld:pubmed
pubmed-article:11389021pubmed:articleTitleSevere impairment of leukocyte rolling in venules of core 2 glucosaminyltransferase-deficient mice.lld:pubmed
pubmed-article:11389021pubmed:affiliationDepartment of Biomedical Engineering, University of Virginia Health Sciences Center, Charlottesville, VA 22908, USA.lld:pubmed
pubmed-article:11389021pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11389021pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11389021pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:14537entrezgene:pubmedpubmed-article:11389021lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11389021lld:pubmed